Root Financial Partners’s Neuronetics STIM Stock Holding History

Root Financial Partners’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-77	Closed	-$112	–	2824
2026 Q1	$112	Buy	+77	New	+$122	﹤0.01%	3260

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Root Financial Partners's STIM Position: Q2 2026 in Review

Root Financial Partners sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 77 shares — an estimated $112 sold.

Root Financial Partners first reported a position in STIM in Q1 2026 and held it in 1 quarter. The position peaked at $112 in Q1 2026. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

Root Financial Partners reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
Root Financial Partners sold 77 Neuronetics shares in Q2 2026, an estimated $112.
Root Financial Partners first reported a position in Neuronetics in Q1 2026 and held it in 1 quarter.
Root Financial Partners's Neuronetics position peaked at $112 in Q1 2026.
86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.